HTTP Interface and External Systems for IVD Diagnostic Reagent Clinical Trial Prescreening

IVD diagnostic reagent clinical trial prescreening data originates from patient medical record systems, laboratory information systems (LIS), and

Data Characteristics

IVD diagnostic reagent clinical trial prescreening data originates from patient medical record systems, laboratory information systems (LIS), and picture archiving and communication systems (PACS) across multi-center clinical studies. This data is often structured (e.g., lab reports, gene sequencing results) or semi-structured (e.g., physician notes, imaging interpretation reports). Data update frequency varies by trial stage and type, ranging from daily (e.g., blood counts, biochemical markers) to weekly (e.g., tumor markers, gene expression profiles). Document structures typically adhere to clinical research protocols (e.g., CRF forms) and regulatory requirements from the National Medical Products Administration (NMPA) or the U.S. Food and Drug Administration (FDA). Fields include patient demographics, diagnostic results, various biomarker indicators, device parameters, and adverse event records. Units are largely standardized, such as mmol/L, μg/mL, copies/mL, ng/mL, but minor discrepancies may exist between different laboratories or devices, requiring unified calibration.

Constraints from "HTTP Interface and External Systems"

The diversity and high update frequency of IVD diagnostic reagent clinical trial prescreening data demand real-time performance and stability from HTTP interfaces. Structured data requires efficient parsing and mapping mechanisms. Semi-structured data relies on Natural Language Processing (NLP) for information extraction. The wide range of data sources necessitates external system integration to support various data formats (e.g., JSON, XML, HL7) and handle heterogeneity between different data sources. Real-time data updates require interfaces with high concurrency processing capabilities to manage a rapid influx of test results. Clinical trial data sensitivity dictates that interfaces must employ strict security authentication (e.g., OAuth2.0, API Key) and transport encryption (HTTPS). Complex business logic, such as patient inclusion criteria determination and exclusion criteria validation, must be implemented at the interface level to reduce the computational burden on downstream systems. Data traceability also requires interfaces to log detailed call records and data processing.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
maxRequestTimeout60 secondsClinical data volumes are large, and complex queries can be time-consuming. A longer timeout prevents disconnections.
concurrencyLimit50This balances the concurrency capabilities of external LIS/PACS systems with FastGPT platform processing capacity, preventing overload.
authMethodOAuth2.0Clinical data is sensitive. OAuth2.0 provides a more secure authorization mechanism.
dataSchemaValidationEnabled,Strict ModeEnabling strict mode ensures received data conforms to predefined structures, preventing processing failures due to inconsistent data formats.
retryStrategyExponential Backoff,Max Retries 3 timesThis addresses network fluctuations or transient external system failures, improving data acquisition success rates.
payloadCompressThreshold1024 KBCompression is enabled for request or response bodies exceeding this threshold. This reduces network transfer overhead, especially for large data like imaging or gene sequencing reports.

Common Pitfalls

  • An HTTP request returns a 5xx error code, but the external system indicates data was processed. This occurs when the interface timeout is too short; the external system completes processing, but the FastGPT end has already disconnected.
  • Some patient lab report fields are empty, leading to inaccurate prescreening results. This typically happens when the data format returned by the external system does not fully match the predefined data model, due to missing field mappings or incomplete data cleansing rules.
  • File upload fails with a file size limit error. This is because the UPLOAD_FILE_MAX_SIZE parameter is not adequately configured for potentially large imaging or raw gene sequencing data files in IVD diagnostic reagents.

How to Verify Configuration

  • Perform stress tests on the integrated interface using simulated actual clinical trial data. Observe if the interface response time remains stable within maxRequestTimeout and check for complete data transmission under concurrent requests.
  • Randomly select multiple IVD diagnostic reagent clinical trial data sets from different sources (LIS, PACS). Upload them via the interface and verify the accuracy of data types, units, and values for corresponding fields within FastGPT. Compare the original data with the processed data.
  • Intentionally construct data with abnormal values, missing fields, or incorrect formats. Test if the interface's dataSchemaValidation configuration correctly identifies and rejects non-compliant data or processes it according to predefined rules.
  • Check system logs to confirm that the authMethod configuration's authentication token refresh mechanism is working correctly, with no request failures due to expired tokens.

Note: The values provided are common starting points. Measure them against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.